Testing effectiveness (Phase 2)Study completedNCT01759888
What this trial is testing
Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
Who this might be right for
Parkinson's Disease
Chang Gung Memorial Hospital 49